OptiBiotix Health PLC (LON:OPTI) said it has extended its manufacturing, supply and profit-sharing agreement with Agropur MSI to include WellBiome, developed to promote gut health.
Agropur already has the rights to weight management range SlimBiome in the US, Canada and Mexico.
Dr Fred Narbel, managing director of OptiBiotix’s prebiotics division, said the enhanced deal recognised its partner’s success in building sales of SlimBiome.
First deliveries in the territory occurred in the second quarter.
“The agreement extends terms to support further sales growth and is a third commercial step in bringing our new functional ingredient WellBiome to global markets and building brand awareness,” Narbel added in a statement.
“This is an important agreement as it will help OptiBiotix access a wider range of customers in North America, a market where the understanding of the microbiome is gaining momentum.”
OptiBiotix is a specialist in the human microbiome, the ecosystem of bacteria that resides in the gut and on the skin.
Its new approach to wellbeing has seen it develop compounds to tackle obesity, high cholesterol and diabetes.